Physician profile
Donita Dyalram
NPI 1013107572
$112,078.94
in general payments reported to CMS, 2019-2025
5 companies · $46K in 2025
The $46K reported for 2025 was more than what 99% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,963 · 2020: $1,919 · 2021: $6,360 · 2022: $16K · 2023: $31K · 2024: $4,521 · 2025: $46K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $66K · Travel and Lodging: $12K · Food and Beverage: $1,889 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $66,400.00 |
| Travel and Lodging | $11,584.49 |
| Food and Beverage | $1,889.03 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,062.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $102,963.05 | 2019-2025 | Na, Vsp System, Vsp Cranial, Medpor Titan |
| Axogen | $8,347.82 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Kls-Martin L.P. | $668.72 | 2021-2025 | |
| 3d Systems | $56.94 | 2022 | |
| Baxter Healthcare | $42.41 | 2019-2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donita Dyalram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.